Get a free quote now.
Continual Improvement of Vancomycin AUC Dosing
Why (and How) to Identify the Most Predictive Model for your Organization
The 2020 vancomycin guidelines have prompted an expanded desire to understand and evaluate pharmacokinetic models. In this presentation, Jon Faldasz, PharmD BCPS shares some recent developments in understanding and evaluating vancomycin pharmacokinetic models from the InsightRX Data Science team, and proposes a new democratized approach to performing research and optimizing patient care.